Page last updated: 2024-08-26

arginyl-glycyl-aspartic acid and mannose-6-phosphate

arginyl-glycyl-aspartic acid has been researched along with mannose-6-phosphate in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dumler, I; Haller, H; Kiyan, J; Kiyan, R; Shushakova, N; Tkachuk, N; Tkachuk, S1
Fretz, MM; Kok, RJ; Temming, K1

Reviews

1 review(s) available for arginyl-glycyl-aspartic acid and mannose-6-phosphate

ArticleYear
Organ- and cell-type specific delivery of kinase inhibitors: a novel approach in the development of targeted drugs.
    Current molecular pharmacology, 2008, Volume: 1, Issue:1

    Topics: Drug Carriers; Drug Delivery Systems; Humans; Liposomes; Mannosephosphates; Oligopeptides; Organoplatinum Compounds; Platinum Compounds; Polyethylene Glycols; Protein Kinase Inhibitors; Signal Transduction

2008

Other Studies

1 other study(ies) available for arginyl-glycyl-aspartic acid and mannose-6-phosphate

ArticleYear
Urokinase induces survival or pro-apoptotic signals in human mesangial cells depending on the apoptotic stimulus.
    The Biochemical journal, 2008, Oct-15, Volume: 415, Issue:2

    Topics: Apoptosis; bcl-Associated Death Protein; Biological Transport; Blotting, Western; Cells, Cultured; Enzyme-Linked Immunosorbent Assay; Extracellular Signal-Regulated MAP Kinases; Glucose; Humans; Immunoprecipitation; In Situ Nick-End Labeling; Mannosephosphates; Mesangial Cells; Microscopy, Confocal; Microscopy, Fluorescence; Nuclear Envelope; Oligopeptides; Oncogene Protein v-akt; Receptors, Urokinase Plasminogen Activator; Signal Transduction; Urokinase-Type Plasminogen Activator

2008